What’s hot? News From Across the Specialty

In this monthly column, members of the DermWorld Editorial Advisory Workgroup identify exciting news from across the specialty. Dr. Matarasso discusses a new addition to the HA class of dermal fillers.

Since the first injectable hyaluronic acid (HA) was FDA approved in 2003, there have been new HA formulations and expanded indications. Physicians can now select from a large portfolio of HA fillers with different features including HA molecular weight and concentration and degree of crosslinking (also referred to as degree of modification). Physicians using these devices must be familiar not only with anatomical age-related volume loss, but the different rheological properties of each HA filler.

Click here to read more!